281 related articles for article (PubMed ID: 17106451)
1. The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy.
Ueno NT; Cheng YC
Bone Marrow Transplant; 2006 Dec; 38(11):711-4. PubMed ID: 17106451
[No Abstract] [Full Text] [Related]
2. Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effect.
Takami A; Takamatsu H; Yamazaki H; Ishiyama K; Okumura H; Ohata K; Konaka H; Asakura H; Namiki M; Nakao S
Bone Marrow Transplant; 2006 Dec; 38(11):729-32. PubMed ID: 17028623
[TBL] [Abstract][Full Text] [Related]
3. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].
Cheng YC; Ueno NT
Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734
[TBL] [Abstract][Full Text] [Related]
4. What's past is prologue: lessons learned and the need for further development of allogeneic hematopoietic stem cell transplantation for renal cell carcinoma.
Ueno NT; Childs RW
Biol Blood Marrow Transplant; 2007 Jan; 13(1):31-3. PubMed ID: 17222750
[No Abstract] [Full Text] [Related]
5. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
Takahashi Y; Childs RW
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for renal cell carcinoma.
Bregni M; Herr W; Blaise D;
Expert Rev Anticancer Ther; 2011 Jun; 11(6):901-11. PubMed ID: 21707287
[TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.
Childs RW
Crit Rev Immunol; 2001; 21(1-3):191-203. PubMed ID: 11642604
[TBL] [Abstract][Full Text] [Related]
8. Long-term graft-versus-tumor effect following reduced intensity hematopoietic stem cell transplantation in a child with metastatic renal cell carcinoma.
Baek HJ; Han DK; Hwang TJ; Bae SH; Choi YD; Kook H
Pediatr Blood Cancer; 2012 Sep; 59(3):583-5. PubMed ID: 22231905
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.
Arya M; Chao D; Patel HR
Nat Clin Pract Oncol; 2004 Nov; 1(1):32-8. PubMed ID: 16264797
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.
Demirer T; Barkholt L; Blaise D; Pedrazzoli P; Aglietta M; Carella AM; Bay JO; Arpaci F; Rosti G; Gurman G; Niederwieser D; Bregni M;
Nat Clin Pract Oncol; 2008 May; 5(5):256-67. PubMed ID: 18398414
[TBL] [Abstract][Full Text] [Related]
11. Treatment of renal-cell cancer by transplantation of allogeneic stem cells.
Spitzer TR; Sykes M
N Engl J Med; 2001 Jan; 344(2):137-8. PubMed ID: 11188409
[No Abstract] [Full Text] [Related]
12. Non-myeloablative allogeneic stem cell transplantation: a promising new therapy in the management of metastatic renal cell cancer.
Arya M; Gommersall LM; Shergill IS; Patel HR; Chao D
BJU Int; 2005 Sep; 96(4):474-5. PubMed ID: 16104893
[No Abstract] [Full Text] [Related]
13. Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
Nelson RP; Logan TF; Abonour R
Bone Marrow Transplant; 2002 Dec; 30(12):805-12. PubMed ID: 12476272
[TBL] [Abstract][Full Text] [Related]
14. Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases.
Childs RW
Cancer J; 2000; 6(3):179-87. PubMed ID: 10882334
[No Abstract] [Full Text] [Related]
15. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
Nakayama K; Tannir NM; Liu P; Wathen JK; Cheng YC; Champlin RE; Ueno NT
Biol Blood Marrow Transplant; 2007 Aug; 13(8):975-85. PubMed ID: 17640602
[TBL] [Abstract][Full Text] [Related]
16. Reduced-intensity allogeneic stem cell transplantation for renal cell carcinoma: in vivo evidence of a graft-versus-tumor effect.
Takami A; Asakura H; Koshida K; Namiki M; Nakao S
Haematologica; 2004 Mar; 89(3):375-6. PubMed ID: 15020287
[TBL] [Abstract][Full Text] [Related]
17. Treatment of renal-cell cancer by transplantation of allogeneic stem cells.
Poller DN
N Engl J Med; 2001 Jan; 344(2):137; author reply 138. PubMed ID: 11188411
[No Abstract] [Full Text] [Related]
18. Evidence of graft-versus-tumour effect following allogeneic haematopoietic stem cell transplantation in renal cancer other than clear cell type.
Secondino S; Pedrazzoli P; Giannetta L; Schiavetto I; Vanzulli A; Siena S
Bone Marrow Transplant; 2004 Nov; 34(10):917-8. PubMed ID: 15361912
[No Abstract] [Full Text] [Related]
19. Allogeneic stem cell transplantation for patients with metastatic renal cell carcinoma.
Roigas J; Johannsen M; Ringsdorf M; Massenkeil G
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1449-58. PubMed ID: 17069529
[TBL] [Abstract][Full Text] [Related]
20. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
